Identified p75 as the first biochemical marker of ALS progression

This work was done in collaboration with Dr. Mary-Louise Rogers, Flinders University, Australia.

As of 2021, urinary p75 remains the only biofluid-based biomarker of disease progression in patients with clinically manifest ALS.